The World Market for Molecular Diagnostics, 13th Edition
Explore the Future of Molecular Diagnostics: Market Insights and Opportunities
The molecular diagnostics market, a driving force within the global in vitro diagnostics (IVD) industry, continues to thrive several years post-pandemic, offering significant growth opportunities across infectious diseases, cancer, and transplant diagnostics. Kalorama Information's latest report, The World Market for Molecular Diagnostics, 13th Edition, provides an unparalleled deep dive into this dynamic sector, revealing key trends, applications, and innovations shaping the market from 2024 to 2029.
Why This Report is a Must-Have:
- Comprehensive Market Insights: Analyze global and regional molecular diagnostics markets, segmented by application areas such as infectious diseases, blood screening, cancer, and histology.
- Cutting-Edge Trends: Understand how technologies like Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), and ISH are transforming healthcare.
- Competitive Intelligence: Gain strategic insights into major players, including Roche Diagnostics, Thermo Fisher Scientific, and Illumina, along with emerging competitors.
- Strategic Guidance: Navigate complex markets with detailed forecasts and actionable data to identify high-growth areas and untapped opportunities. Key Market Highlights:
- Molecular diagnostics plays a vital role in precise disease detection and treatment, from identifying antimicrobial-resistant infections to supporting personalized cancer therapies.
- The demand for molecular diagnostics is surging in both developed and emerging markets, with North America and Europe leading adoption.
- Segments like molecular infectious disease diagnostics, cancer diagnostics, and transplant diagnostics are driving innovation and growth.
- Executive Summary
- Size of Molecular Diagnostics Market
- Table Molecular Diagnostics Global Market (COVID-19 and without COVID-19), 2023 vs 2024 ($ million)
- Table Molecular Diagnostics Global Market (COVID-19 and without COVID-19), 2023 vs 2024 ($ million)
- Table Molecular Diagnostics Global Market (COVID-19 and without COVID-19), 2024 ($ million)
- Table Overall Molecular Diagnostics Global Market, 2023, 2024, 2029 ($ million)
- Growth Areas in Molecular Diagnostics
- Table Growth Applications, by Segment Revenue Growth, 2024-2029 (%) (Cancer Assays, Circulating Tumor Cells, HAIs/Sepsis, Hepatitis, Histology [ISH, FISH], HIV, Inherited/Genetic, Molecular HPV, NIPT, Respiratory, STIs, Transplantation, Tuberculosis [TB])
- Table Growth Applications, by Revenue Growth, 2024-2029 (%) (Cancer Assays, Circulating Tumor Cells, HAIs/Sepsis, Hepatitis, Histology [ISH, FISH], HIV, Inherited/Genetic, Molecular HPV, NIPT, Respiratory, STIs, Transplantation, Tuberculosis [TB])
- Recent Developments
- Emerging Trends
- Table Selected Molecular POC Diagnostic Platforms, 2024
- Emerging Trends
- Other Developments in Molecular Diagnostics, 2023-2024
- Size of Molecular Diagnostics Market
- Molecular Diagnostics Market
- Recent Brisk Activity
- Recent Product Introductions and Regulatory Approvals
- Table Recent Product Introductions, 2018-2024
- Table Regulatory Approvals and Announcements, 2019-2024
- Recent Product Introductions and Regulatory Approvals
- Market Size and Forecast by Segments
- Table Molecular Diagnostic Market, by Segment, 2024 and 2029 ($ million) (Circulating Tumor Cells; Genetic [Inherited/Genetic, NIPT]; Infectious: [COVID, HAIs/Sepsis, Hepatitis, HIV, Respiratory, STIs, TB, Other]; NAT Blood Screening; Oncology [Cancer Assays, Histology [ISH/FISH], Molecular HPV]; Transplantation)
- Table Molecular Diagnostic Market, by Segment, 2024 and 2029 ($ million) (Circulating Tumor Cells, Genetic; Infectious, NAT Blood Screening, Oncology, Transplantation)
- Table Infectious Molecular Diagnostic Market, Sales by Segment, 2024 and 2029 ($ million) (COVID, HAIs/Sepsis, Hepatitis, HIV, Respiratory, STIs, TB, Other)
- Table Infectious Molecular Diagnostic Market, by Segment Share, 2024 (%) (COVID, HAIs/Sepsis, Hepatitis, HIV, Respiratory, STIs, TB, Other)
- Table Genetic Molecular Diagnostic Market, Sales by Segment, 2024 and 2029 ($ million) (Inherited/Genetic, NIPT)
- Table Genetic Molecular Diagnostic Market, by Segment Share, 2024 (%) (Inherited/Genetic, NIPT)
- Table Oncology Molecular Diagnostic Market, Sales by Segment, 2024 and 2029 ($ million) (Cancer Assays, Histology [ISH/FISH], Molecular HPV)
- Table Oncology Molecular Diagnostic Market, by Segment Share, 2024 (%) (Cancer Assays, Histology [ISH/FISH], Molecular HPV)
- Table Molecular Diagnostic Market, by Region, 2024 ($ million) (APAC, Europe, North America, Rest of World)
- Table Molecular Diagnostic Market, by Region, 2024 ($ million) (APAC, Europe, North America, Rest of World)
- Table Molecular Diagnostics Market Share, by Region, 2024 (%) (APAC, Europe, North America, Rest of World)
- Infectious Diseases
- Table Selected Molecular Hepatitis Tests
- HIV Market and COVID-19 Impact
- Table Selected Molecular Test Products for HIV
- NAT Blood Screening
- COVID-19 Impact
- Molecular Histology and Cytology Diagnostics
- HPV
- Product Developments
- Markets for Molecular Cancer Diagnostics
- Molecular Transplant Diagnostics
- Table Selected Innovations in the Field of Molecular Transplant Diagnostics
- Molecular Inherited Diseases Diagnostics
- Thrombophilia and Coagulation Markers
- Non-Invasive Prenatal Testing (NIPT)
- Inherited Disease Tests
- Molecular Diagnostics Market Deals, Collaborations, Acquisitions
- Table Molecular Diagnostics Market Deals, Collaborations, Acquisitions, 2018-2024
- Recent Brisk Activity
- Trends to Watch - Sequencing, CRISPR, Automation
- Sequencing
- NGS and Companion Diagnostics
- Table Selected Clinical NGS Platforms
- Outlook for NGS in Molecular Diagnostics
- Table Percent of the MDX Market Revenues, by Test Technique, 2024 (%) (ISH, Microarrays, NGS, PCR)
- Table Percent of the MDX Market Revenues, by Test Technique, 2024 (%) (ISH, Microarrays, NGS, PCR)
- Evolving Informatics Solutions in Clinical Sequencing
- Sample Preparation and Quality Control
- NGS and Companion Diagnostics
- Lab Automation and Molecular Diagnostics
- Table Selected Automated/ Integrated Molecular Test Instrument Platforms
- Gene Editing Applications in Molecular Diagnostics
- CRISPR and Diagnostic Applications
- Table Selected Gene Editing / CRISPR Innovations
- CRISPR and Diagnostic Applications
- Sequencing
- Company Profiles
- Abbott Diagnostics
- Company Overview
- Financial Review
- Table Abbott Diagnostics' Revenue History, 2017-2023 ($ billion)
- Table Abbott Diagnostics' Molecular Diagnostic Revenue History, 2016-Q3 2024 ($ million)
- Table Abbott Rapid Diagnostics Revenue History, Q4 2017-Q3 2024 ($ million)
- FDA approval of Alinity m STI assay and High Risk HPV Assay
- FDA approval of ALK Break Apart FISH Probe Kit
- Alinity s System
- WHO prequalification (PQ) approval of viral load test
- Advanced Cell Diagnostics (Bio-Techne)
- Company Overview
- Agena Bioscience
- Company Overview
- Agendia BV
- Company Overview
- Agilent Technologies (incl. Dako)
- Company Overview
- Financial Review
- Table Agilent Diagnostics and Genomics Segment Revenues, Fiscal 2016- Q3 2024 ($ million)
- Genomics
- Cytogenetic Analysis
- Sequencing
- Altona Diagnostics
- Company Overview
- Amoy Diagnostics
- Company Overview
- Applied Spectral Imaging
- Company Overview
- ARUP Laboratories
- Company Overview
- Asuragen Inc. (Bio-Techne)
- Company Overview
- Becton, Dickinson & Co. (BD)
- Company Overview
- Business Segments
- Acquisitions
- Divestitures
- Leading Position in the Flow Cytometry Market
- Cytology
- Revenue and Growth
- Table BD Life Sciences Unit Quarterly Revenues, Fiscal 2018-Q4 2024 ($ million)
- Molecular Diagnostics Focus
- Beijing Genomics Institute (BGI)
- Company Overview
- PCR and Fluorescence
- MGI Tech Co., Ltd.
- Prenatal Testing
- Test Services
- Whole Genome Sequencing (WGS)
- NGS Sequencing
- Collaborations
- Berry Genomics
- Company Overview
- binx health
- Company Overview
- Bio-Rad Laboratories, Inc.
- Company Overview
- Recent Revenue History
- Table Bio-Rad Diagnostics Revenue History, 2017-2023 ($ million)
- Liquid Biopsy
- Droplet Digital PCR
- Sequencing
- Biocartis
- Company Overview
- Financial Review
- Table Biocartis' Revenue History, 2017-2023 ($ million)
- Products and Technologies
- Biodesix
- Company Overview
- bioMérieux
- Company Overview
- Table bioMérieux’s Revenue History, Molecular Biology and Microbiology Segments, 2016-Q1 2024 (€million)
- BIOFIRE Business
- Molecular Diagnostics
- Company Overview
- CareDx, Inc.
- Company Overview
- Table CareDx Revenue, 2017-Q3 2024 ($ million)
- Testing Services Offered by CareDx
- Company Overview
- Danaher
- Company Overview
- Danaher’s 2023 Performance
- Table Danaher Major Segment Revenues by Quarter, Q1 2018-Q3 2024 ($ million)
- Life Sciences Business
- Diagnostics Business
- Cepheid
- GeneXpert / Xpress Line
- Tuberculosis
- Microbiology
- POC STI Testing
- Cancer
- Leica Biosystems
- DiaSorin
- Company Overview
- Molecular Diagnostics
- Molecular Oncology
- Expansion
- Eiken Chemical
- Company Overview
- Product News
- Exact Sciences Corp.
- Company Overview
- Recent Revenues and Developments
- Greiner Bio-One GmbH
- Company Overview
- Grifols, S. A
- Company Overview
- Molecular Immunohematology and Specialty Testing Products
- NAT Blood Screening
- Hologic, Inc.
- Company Overview
- Table Hologic Diagnostics Revenues, Calendar Q4 2019-Q3 2024 ($ million)
- Table Hologic's Diagnostics Revenue History, by Segment, Fiscal 2017-2023 ($ million)
- Acquisitions
- PANTHER Molecular System
- HIV Testing
- Sexually Transmitted Infections
- Infectious Diseases
- Panther Fusion
- Company Overview
- Illumina, Inc.
- Table Illumina's Revenue History, 2015-2023 ($ million)
- Table Illumina's Revenue History, 2017-Q3 2024 ($ million)
- China
- Meridian Bioscience Inc
- Company Overview
- Table Meridian Bioscience Pre-Merger Revenues, Calendar Q1 2015-Q4 2022 ($ million)
- Company Overview
- Myriad Genetics, Inc.
- Company Overview
- Table Myriad Genetics Revenue History, 2017-2023 ($ million)
- Company Overview
- NanoString Technologies, Inc.
- Company Overview
- Oxford Nanopore Technologies Ltd
- Company Overview
- Promega Corporation
- Company Overview
- Qiagen
- Company Overview
- Table QIAGEN's Revenue History, 2017-2023 ($ million)
- Molecular Expansion
- Precision Medicine / Companion Diagnostics
- Molecular Microbiology
- Prenatal Testing
- Next Generation Sequencing
- Sample Prep, Informatics
- Digital PCR
- Liquid Biopsy
- Cervical Cancer
- Expansion and Other Developments
- Company Overview
- QuantuMDx Group
- Company Overview
- QuidelOrtho
- Company Overview
- The Solana Business
- Molecular – Savanna
- Revvity
- Company Overview
- Diagnostics
- Sequencing /Genomics
- Liquid Biopsy
- Histology
- Prenatal Business
- Lab Services
- Rheonix, Inc.
- Company Overview
- Roche Diagnostics
- Company Overview
- Financial Review
- Table Roche Quarterly Molecular Diagnostics Revenues, Q1 2016-Q2 2024 ($ million)
- Table Roche Diagnostics' Revenue History, 2016-2023 ($ million)
- Molecular Expansion
- Core Molecular
- Digital PCR
- HPV
- HIV
- Coagulation
- cobas Liat System – POC
- Blood Bank
- Transplant Medicine
- Cancer Companion Testing
- IT in Anatomical Pathology
- Information Technology
- Other Recent Developments
- Seegene
- Company Overview
- Sekisui Diagnostics LLC
- Company Overview
- Sherlock Biosciences
- Company Overview
- Standard BioTools
- Company Overview
- T2 Biosystems
- Company Overview
- Thermo Fisher Scientific Inc.
- Company Overview
- Table Thermo Fisher Scientific Estimated Clinical Diag. and NGS Revenues, 2017-2023 ($ million)
- Table Thermo Fisher Scientific Estimated Revenues by IVD Test Segment, 2017-2023 ($ million)
- Microbiology
- Molecular Test Business
- Next Generation Sequencing
- qPCR
- Oncology Companion Diagnostics
- Transplant Medicine
- Microbiome
- Other Collaborations and Acquisitions
- Gene Editing and Cell Therapy
- China
- Company Overview
- Vela Diagnostics
- Company Overview
- Veracyte, Inc.
- Company Overview
- Abbott Diagnostics
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook